Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™

Inclusion Criteria: * Healthy participants 1 to 40 years of age at enrollment * Participants/Parent(s)/Legally authorized representative (LAR) willing to provide written informed consent to participate study voluntarily * Participants/Parent(s)/LAR who can be followed up during the study period and can comply with the study requirements Exclusion Criteria: * Known history of hypersensitivity reactions to other preventive vaccines * Severe chronic diseases or medical conditions based on the medical judgment of the investigator. In particular, a participant with a) chronic infection such as tuberculosis, or sequel of poliomyelitis, b) known history of immune function disorders, c) chronic use of systemic steroids (\>2 mg/kg/day or \>20 mg/day prednisone equivalent for periods exceeding 10 days)/cytotoxic drugs/immunosuppressants within past 6 weeks, d) active malignancy with the exception of adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated Stage I cancer from which the participant is currently in complete remission, or any other cancer from which the participant has been disease-free for 5 years, e) Congestive heart failure, f) myocardial infarction within the previous 6 months, g) known HIV-infected patients, h) neurological and/or psychiatric disorder, or i) known history of uncontrolled coagulopathy or blood disorders * Participant who planned to or has received other vaccines from 1 month prior to test vaccination ex…